Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial

AIMS: Metal absorbable scaffolds constitute a conceptually attractive alternative to polymeric scaffolds. Promising 6-month outcomes of a second-generation drug-eluting absorbable metal scaffold (DREAMS 2G), consisting of an absorbable magnesium scaffold backbone, have been reported. We assessed the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Heart J
Autors principals: Haude, Michael, Ince, Hüseyin, Abizaid, Alexandre, Toelg, Ralph, Lemos, Pedro Alves, von Birgelen, Clemens, Christiansen, Evald Høj, Wijns, William, Neumann, Franz-Josef, Kaiser, Christoph, Eeckhout, Eric, Lim, Soo Teik, Escaned, Javier, Onuma, Yoshinobu, Garcia-Garcia, Hector M., Waksman, Ron
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
Fasttrack Clinical
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5037291/
https://ncbi.nlm.nih.gov/pubmed/27190094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehw196
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars